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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) replicates primarily in pulmonary alveolar macrophages 
(PAMs) and the resulting lung damage is influenced by strain virulence. To better understand the pathogenesis of 
PRRSV infection, we performed a longitudinal study of the PAM population and lung cytokines in specific pathogen‑
free pigs infected either with the highly pathogenic Lena strain or with the low pathogenic Finistere strain in com‑
parison to uninfected pigs. Bronchoalveolar lavage fluid (BALF) and blood were collected to follow viral, cellular and 
cytokine changes in lung with respect to clinical signs and systemic events. Compared to Finistere‑infected pigs, 
Lena‑infected pigs exhibited more severe clinical signs and 10‑ to 100‑fold higher viral loads in BALF and blood. 
Similarly, they showed an earlier drop in BALF cell viability and phagocytic activity along with a decrease in the 
macrophage count. From 8 to 15 days post‑infection (dpi), monocytes increased both in BALF and blood from Lena‑
infected pigs. BALF and blood showed contrasting cytokine patterns, with low increase of IFN‑α and TNF‑α levels 
and high increase for IL‑1α and IL‑8 in BALF after Lena‑infection. In contrast, in the blood, the increase was marked 
for IFN‑α and TNF‑α but limited for IL‑1β and IL‑8. Down‑regulation of PAM functions combined with inflammatory 
cytokine and monocyte recruitment may promote lung pathogenesis and virus replication in PRRSV infections with 
the highly pathogenic Lena strain. In contrast, the low pathogenic Finistere strain showed prolonged viral replication 
in lung, possibly related to the weak IFN‑γ response.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) 
is one of the most costly diseases for the swine industry 
worldwide, affecting both breeding and growing pigs [1]. 
PRRS is a viral disease that is characterized by reproduc-
tive failure in sows and by respiratory disorders, growth 
retardation and increased mortality in young piglets. 
The clinical manifestation of the disease depends on the 
PRRS viral strain, host and environmental factors and the 
presence of other pathogens [2].
The causative agent of PRRS is an enveloped virus with 
a 15  kb positive polarity single-stranded RNA genome, 
a member of the Arteriviridae family [3]. Strains of the 
PRRS virus (PRRSV) cluster into two different genotypes, 
initially geographically separated: the European geno-
type 1 and the North American genotype 2. Currently, 
both genotypes circulate globally [4]. PRRSV strains 
show great genetic and antigenic diversity along with 
large differences in pathogenicity [5]. PRRSV strains that 
have emerged in Eastern Europe in the past decade have 
widely extended the diversity of genotype 1 which is now 
divided into four subtypes [6]. Strains identified as geno-
type 1 subtype 3 (1.3) show higher pathogenicity in pigs 
than genotype 1.1 strains that have historically circulated 
in Europe, inducing high fever and severe respiratory 
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disorders that exacerbate morbidity and mortality [7, 8]. 
The introduction of subtype 3 in Western Europe has 
the potential to adversely affect the large swine industry 
found in these countries.
After oronasal transmission, PRRSV initially colonizes 
the respiratory tract and plays an immunomodulatory 
role that delays or weakens host responses, leading to 
long virus persistence in the host [9]. The main target 
cells for virus replication are pulmonary alveolar mac-
rophages (PAMs) [10]. Macrophages play a central role in 
immunity interfacing innate and adaptive responses. In 
lung, PAMs are crucial cells in homeostasis and defence 
against microbial invasion with particular ability to rec-
ognize and clear pathogens without inducing inflam-
mation that disturbs gas exchanges [11]. These cells are 
highly phagocytic and express numerous receptors to 
recognize pathogens and initiate the innate immune 
response [12]. In haemostatic conditions, PAMs rep-
resent the major cell type found in the alveolar envi-
ronment and low cytokine levels are measured. After 
pulmonary infection or injury that overwhelms this first-
line defence mechanism, cellular and molecular changes 
can occur toward a strong inflammatory process. PAMs 
can produce a large range of cytokines and chemokines 
that mediate the activation or the recruitment of various 
immune cells into the lungs to reinforce host defences 
against pathogen invasion [12–14].
Pro-inflammatory cytokines, such as interferon-alpha 
(IFN-α), tumour necrosis factor-alpha (TNF-α) and inter-
leukin (IL)-1 have been shown to play a key role in res-
piratory disease severity. Compared to other respiratory 
pathogens, PRRSV infection induces limited pro-inflam-
matory cytokine production in the lungs [15]. However, 
in pigs infected by highly pathogenic (HP) strains, high 
levels of TNF-α, IL-1 and IL-6 have been quantified in 
lung or in blood [16–19].
To better understand the pathogenicity of HP-PRRSV 
strains, especially at the pulmonary level, we compared 
the dynamic changes induced in alveolar environment 
after the genotype 1.3 HP Lena strain infection with 
those induced by the genotype 1.1 low pathogenic (LP) 
Finistere strain infection. Previous papers on Lena strain 
pathogenicity mainly focused on blood by longitudinal 
sample collection [17] or in the lungs but only through 
sequential slaughtering [20]. Our study presents an origi-
nal strategy combining simultaneous local and systemic 
analyses to identify lung-specific modulations in cellular 
populations, viability and phagocytic activity, as well as in 
cytokine levels. We focused our study on PAMs using a 
longitudinal monitoring for 42  days post-infection (dpi) 
to detect any correlations between clinical, virological, 
and immunological parameters. Moreover, we used spe-
cific pathogen-free (SPF) pigs with very high health level, 




The LP genotype 1.1 Finistere PRRSV strain (PRRS-
FR-2005-29-24-1) was isolated in France in 2005 from 
a herd with reproductive failures in sows (abortions). 
In SPF pigs, Finistere infection induces a mild clinical 
expression [21]. The HP genotype 1.3 Lena PRRSV strain 
was kindly provided by Dr Hans Nauwynck, (Univer-
sity of Ghent, Belgium). The Lena strain was isolated in 
Belarus in 2007 from a herd with mortality, reproductive 
failures and respiratory disorders [7]. Both viruses were 
propagated and titrated on PAMs for 2 and 5 passages for 
the Finistere and the Lena strains, respectively.
Animal experiment design
Six-week-old SPF Large White pigs from our biosecurity 
level-3 air-filtered facilities, with high health status and, 
in particular, free of numerous respiratory pathogens 
such as PRRSV, swine Influenza virus, porcine circovirus 
type 2, Mycoplasma hyopneumoniae, Actinobacillus pleu-
ropneumoniae, Pasteurella multocida, Bordetella bron-
chiseptica and Haemophilus parasuis, were randomly 
assigned to three groups housed in three separate rooms: 
one group of eight animals (Lena group) and two groups 
of five animals (Finistere group and Control group). Pigs 
were inoculated by nasal route with either the Finistere 
strain or Lena strain (5.105 CPD50/pig): 2.5  mL of the 
viral suspension was injected into each nostril using a 
5  mL syringe without a needle. The Control group was 
mock-inoculated with MEM culture media.
Rectal temperature, weight gain and clinical score were 
monitored daily using a template from Weesendorp et al. 
[17]. Hyperthermia was reported for rectal temperature 
higher than 40  °C. Blood samples and bronchoalveolar 
lavage fluid (BALF) were collected before infection (on 
day-3) and then at 2, 4, 8, 11, 15, 22, 30, 36 and 43 dpi. 
BALF collections were obtained by infusing 2 × 20 mL of 
warm, sterile PBS instilled in the lungs through a nasogas-
tric probe of 4.5  mm of diameter and 50 or 57  cm long 
depending on the age and the weight of the animals (Lab-
oratoires Euromedis, Neuilly-sous-Clermont, France). 
The BALF collection was performed under general anaes-
thesia obtained by intravenous injection of 5 mg/kg keta-
mine (Clorketam 1000, Vétoquinol SA, Lure, France) and 
1  mg/kg xylazine (2% Rompun, Bayer HealthCare, Lev-
erkusen, Germany). The mean BALF volume collected 
using this procedure was 25  mL. The rare BALF with 
blood contamination were excluded from all the analy-
ses. All pigs were euthanised at 44 or 45 dpi. Post-mortem 
examination was conducted on all pigs after euthanasia.
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The animal experiment was authorised by the French 
Ministry for Research (Authorisation no. 00676.01) and 
approved by the national ethics committee (authorisation 
no. 09/07/13-1).
Sample treatment
Serum samples were purified from coagulated blood 
samples by centrifugation at 3000 ×  g for 5  min. From 
EDTA blood samples, blood cell counts were obtained 
using a MS9.5 haematology analyser (Melet Schloesing 
Laboratoires, Osny, France).
Cells were purified from BALF by centrifugation at 
500 × g for 10 min at 4 °C and counted using a haemocy-
tometer with Trypan blue staining to determine the per-
centage of viability. BALF cells were monitored by flow 
cytometry for phenotypic changes and phagocytic activ-
ity. The remaining cell-free BALF were frozen at −70 °C.
Viral genome quantification
RNA was purified from serum or cell-free BALF using 
the NucleoSpin RNA 8 virus (Macherey-Nagel, Düren, 
Germany) according to the manufacturer’s instructions. 
Specific genome detection for either the Lena strain or 
the Finistere strain was assessed by qRT-PCR using the 
SuperScript III Platinum one step qRT-PCR kit (Life 
Technologies, Carlsbad, CA, USA) using specific prim-
ers and probes of the target gene (Finistere strain ORF5: 
forward primer TATGCGAGCTGAATGGGACC, 
reverse primer AGGATATGAGTGGCAACCGG, 
probe 6FAM-TGGGCAGTTGAGACTTTCGTGCT-
TAM or Lena strain ORF7: forward primer 
AGAACCAGCGCCAATTCAGA, reverse primer 
TCTTTTTCGCCTGTCCTCCC, probe 6FAM-AAACA-
CAGCTCCAATGGGGAATGGC-TAM) or of the 
internal control (porcine beta-actin: forward primer 
CTCGATCATGAAGTGCGACGT, reverse primer 
GTGATCTCCTTCTGCATCCTGTC, probe TET-
ATCAGGAAGGACCTCTACGCCAACACGG-BHQ1). 
RT-PCR reactions were performed with the Chromo4 
real-time PCR device (Bio-Rad, Hercules, CA, USA) for 
30 min at 50 °C, 2 min at 94 °C followed by 45 cycles of 
15 s at 94  °C and 30 s at 60  °C. Genome quantifications 
were obtained using serial dilutions of Finistere or Lena 
strain (known infectious titres) in serum or cell-free 
BALF collected from SPF pigs. Results are given in equiv-
alent (eq) CPD50/mL of serum or BALF.
Antibody assessment
Antibodies against PRRSV were detected using IDEXX 
PRRS X3 ELISA tests (IDEXX laboratories, Liebefeld, 
Switzerland) according the manufacturer’s instructions 
in serum or using a protocol modified for BALF (starting 
dilution at 1:2 instead of 1:40).
Flow cytometry cellular phenotype and phagocytosis 
analyses
BALF cells (5.105 cells) were transferred to microtiter 
plates and washed with PBS for 3  min at 350  ×  g. For 
phenotype analyses, cells were single- or triple-stained 
for swine membrane markers [22], using the following 
primary mouse monoclonal antibodies: phycoerythrin 
(PE)-conjugated anti-porcine CD21 (clone BB6-11C9.6), 
fluorescein isothiocyanate (FITC)-conjugated anti-por-
cine CD3e (clone PPT3), PE-conjugated anti-SWC3 (also 
identified as CD172a; clone 74-22-15), FITC-conjugated 
anti-SWC9 (also identified as CD203a; clone PM18-7), 
unconjugated anti-SWC8 (clone MIL3), or stained with 
the appropriate mouse isotype control: FITC or PE-con-
jugated IgG1 (clone MOPC-21) (all obtained from Bio-
Rad, Hercules, CA, USA, SouthernBiotech, Birmingham, 
AL, USA or Becton, Dickinson and Company, Franklin 
Lakes, NJ, USA). The unlabelled primary antibody was 
detected by goat polyclonal secondary antibody allophy-
cocyanin (APC)-conjugated anti-mouse IgM (Abcam, 
Cambridge, UK) which was also used as isotype control. 
Same cell populations were identified in BALF by flow 
cytometry as in blood using the haematology analyser to 
compare population changes between the two locations. 
For phagocytosis tests, cells were incubated with Trans-
FluoSpheres 488/560  nm fluorescent microspheres (10 
microspheres per cell) for 1 h at 37 °C (Life Technologies, 
Carlsbad, CA, USA) as described by De Baere et al. [23]. 
For phenotyping and phagocytosis tests, flow cytometry 
analyses were performed on a constant event number of 
10  000 cells fixed with 4% paraformaldehyde, acquired 
on a FC500 flow cytometer using MXP 2.1 and analysed 
using Kaluza 1.2 software (all from Beckman Coulter, 
Fullerton, CA, USA). Cytometer parameters and gat-
ing were defined in order to remove cell debris and free 
microspheres from the acquired events. Phenotype data 
were obtained by analysing marker expression on the cell 
surface in the appropriate gate, as described by Nielsen 
et  al. on SSC and FSC parameters for lymphocytic and 
monocytic cells or for macrophages [24]. For phagocyto-
sis analysis, the median fluorescence intensity (MFI) was 
measured, reflecting the quantity of microspheres cap-
tured per cell.
Cytokine measurements
Porcine cytokines were quantified in serum and cell-
free BALF using ELISA kits from Bio-techne for 
TNF-α, IL-1β, IL-8, IL-10 and IFN-γ (Bio-techne, Minne-
apolis, MN, USA). Porcine IFN-α was detected using an 
in-house ELISA test, as previously described [25].
Porcine IL-10 and IFN-γ gene expressions were 
assessed in cells isolated from BALF using the TaqMan-
based triplex real-time RT-PCR described by Petrov et al. 
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which uses both β-actin and GAPDH as endogenous 
controls to normalise the cytokine gene expression [26]. 
Petrov’s RT-PCR was performed with modified protocol 
using the SuperScript III Platinum One-Step Quantita-
tive RT-PCR System (Life Technologies, Carlsbad, USA) 
and previously published primers and probes for IL-10 
and IFN-γ cytokines [27]. The relative expressions of tar-
get genes were calculated using the R = 2−∆∆CT equation 
[28] with regard to the expression level in BALF cells of 
each pig before the infection (−3 dpi).
Statistical tests
The measured variations of each parameter for an 
infected group were compared with that of the Control 
group or the other infected group and analysed daily 
using a global Kruskal–Wallis test to detect global signifi-
cant differences between groups. Then, a Holm’s adjusted 
pairwise Wilcoxon-Mann-Whitney test was added to 
identify specific significant differences between groups. 
Correlation analyses were performed using Spearman’s 
matrix. Statistical tests were performed using R software 
(R Development Core Team, 2008), with the limit of sig-
nificance set at p < 0.05. The error bars on the graphs rep-
resent the standard error (SE).
Results
Clinical data
Animals inoculated with the Finistere strain showed mild 
signs of the disease with an increase in rectal tempera-
ture below the hyperthermic threshold and a very low 
clinical score (Figures 1A and C). Only minor respiratory 
troubles (mild dyspnea, some sneezing and cough) and 
nasal discharge were observed for pigs infected by the 
Finistere strain. One pig also showed typical “blue ears” 
at 11–12 dpi. Weight monitoring of Finistere-infected 
pigs revealed a significant reduction in the average daily 
weight gain (ADWG) the second week of infection (Fig-
ure 1B). All pigs recovered from the infection at the end 
of the experiment at 44–45 dpi. No characteristic lesions 
were observed during necropsy, except for tracheo-
bronchial, mediastinal, inguinal and iliac reactive lymph 
nodes.
Figure 1 Clinical parameters. A Rectal temperature, B average daily weight gain, C clinical score and D survival were monitored. All data are 
reported as the mean (±SE) of results obtained from pigs (n = 5) in the Control or Finistere group or the surviving pigs (n = 5–8) in the Lena group. 
“a” indicates a significant difference between the Control and Lena groups, “b” a significant difference between the Control and Finistere groups 
and “c” a significant difference between the Lena and Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted pairwise 
Wilcoxon‑Mann‑Whitney test (p < 0.05).
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In contrast, pigs infected with the Lena strain showed 
a long period of hyperthermia from 1 to 15 dpi with 
a marked clinical score from 3 to 22 dpi that peaked at 
12 dpi (Figures  1A  and C). Severe respiratory disorders 
with high breathing frequency, cough, sneezing and nasal 
discharge were observed. Apathy and anorexia were also 
recorded and the ADWG of the Lena group dropped sig-
nificantly from the first (p = 0.007) to the fifth (p = 0.035) 
week of infection compared with either the Control 
group or the Finistere group (Figure 1B).
During the experiment, 3 of the 8 pigs died in the Lena 
group (Figure 1D): animal #4915 was found dead at 8 dpi 
whereas its symptoms were not high enough to be sac-
rificed the day before. Pigs #4917 and #4853 had to be 
euthanised respectively at 16 dpi due to very high clini-
cal score and at 22 dpi due to severe anaemia. Necropsy 
of pigs #4915 and #4917 revealed thymus atrophy, dia-
phragmatic rupture, pleurisy, splenomegaly, fibrinous 
peritonitis, as well as hypertrophied and haemorrhagic 
lymph nodes. Pig #4853 showed thymus atrophy, pneu-
monia lung lesions, hypertrophied lymph nodes and 
blood in the stomach and large intestine. As observed 
in Finistere-infected pigs, no specific lesions except for 
reactive lymph nodes were found during necropsy of 
Lena-infected pigs that had recovered from the disease.
Haematological data
Blood lymphocyte counts rapidly decreased in PRRSV-
infected pigs (at 2 dpi) without any significant difference 
between strains. Thereafter, the lymphocyte popula-
tion reached the Control group levels at 11 dpi and then 
exceeded them in the Finistere-infected group at 14 dpi 
(Figure  2A). A four-fold higher blood monocyte count 
was detected from 8 to 14 dpi in the Lena group, whereas 
the increased monocyte level observed at 11 and 14 dpi 
was not significant in the Finistere group (Figure  2B). 
Similar cell dynamics were observed for blood granulo-
cytes, with a significant increase in the granulocyte count 
found at 11 dpi in the Finistere group compared with the 
Control group, but still lower than those observed in the 
Lena group (data not shown). Decreased erythrocyte 
counts were observed for both PRRSV strains at 2 dpi, 
however the duration and the intensity of the decrease 
was exacerbated in the Lena group (Figure  2C). Similar 
patterns were observed for haemoglobin levels (data not 
shown).
Viral load and antibody levels in serum and BALF
Both strains were detected by RT-PCR as early as 2 dpi 
in the sera of all infected animals. The Lena strain viral 
load was 100-fold higher than those of the Finistere strain 
until 11 dpi (Figure 3A). Viral load of both PRRSV strains 
decreased at 21 dpi and were not detected from 36 dpi in 
sera. In BALF, similar viral dynamics were observed (maxi-
mum mean viral load of 2.5.106 eq CPD50/mL at 4 dpi 
for Lena vs 3.8.105 eq CPD50/mL at 11 dpi for Finistere), 
except that the rates of decrease of the Finistere strain viral 
load was significantly slower than those of the Lena strain 
from 22 dpi (p = 0.017 and 0.022 at 22 and 30 dpi, respec-
tively) (Figure 3B). At 30 dpi, the virus was only detected 
in BALF of one out of five Lena-infected pigs, whereas the 
five Finistere-infected pigs were still PRRSV positive.
PRRSV-specific antibodies were detected using ELISA 
from 8 dpi in serum and BALF collected from Lena- or 
Finistere-infected animals, with slightly lower S/P values 
for the Lena strain (Figures 3C and D).
Figure 2 Blood cell count. A Monocyte, B lymphocyte and C erythrocyte counts were obtained using an haematology analyser. All data are 
reported as the mean (±SE) of results obtained for the pigs (n = 5) in the Control or Finistere groups or the surviving pigs (n = 5–8) in Lena group. 
“a” indicates a significant difference between the Control and Lena groups, “b” a significant difference between the Control and Finistere groups 
and “c” a significant difference between the Lena and Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted pairwise 
Wilcoxon‑Mann‑Whitney test (p < 0.05).
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Cell viability and phagocytic activity in BALF
Cell counts showed an increase of cellular concentration in 
BALF with the age of the animals for the 3 groups but with 
no difference between groups (data shown in Additional 
file 1). For both strains, the viability of BALF cells decreased 
during the first two weeks after infection (Figure 4A). The 
proportion of phagocytic cells in BALF was also altered 
by PRRSV infection from 8 to 36 dpi (Figure 4B). Further-
more, the MFI measurement, reflecting the quantity of 
phagocytosed beads per cell, demonstrated a reduction in 
phagocytic activity in BALF cells after PRRSV infection 
(Figure 4C). For the Lena strain, the decrease in the viable 
or phagocytic BALF cell count, as well as the reduction of 
their phagocytic activity, was observed as early as 4 dpi and 
reached minimum values lower than those for the Finistere 
strain (79.3 vs. 84.3%, 54.5 vs. 63.8% and 11.0 vs. 25.9 for 
cell viability, phagocytic cells percentage and MFI of phago-
cytic BALF cells isolated from Lena- vs. Finistere-infected 
pigs, respectively). Numerous cell debris were observed 
among BALF cells and particularly at 8 dpi in Lena-infected 
group and at 11 dpi in Finistere-infected pigs.
BALF cell viability was inversely correlated with viral 
load in BALF calculated for the entire duration of the 
experiment (r  =  −0.72 and −0.57 for Lena- and Finis-
tere-infected group respectively). A similar correlation 
was observed between phagocytic BALF cell percentage 
and viral load in BALF (r = −0.61 for the Lena- or Finis-
tere-infected group).
Dynamics of cell subsets in BALF
Without infection, [SWC3+  , SWC9+  , SWC8−] mac-
rophages constituted the main population within BALF 
cells. After PRRSV infection, the proportion of mac-
rophages decreased from 4 dpi with the Lena strain and 
from 8 dpi for the Finistere strain (Figure  5A). There-
after, the percentage of macrophages remained below 
Figure 3 PRRSV viral load and antibodies in serum and BALF from infected groups. PRRSV genome load was quantified (A) in serum and 
(B) in BALF by RT‑PCR. Antibodies against PRRSV N protein were detected (C) in serum and (D) in BALF using ELISA with a positive threshold set 
at 0.4. All data are reported as the mean (±SE) of results obtained for the pigs (n = 5) in the Finistere group or the surviving pigs (n = 5–8) in Lena 
group. “c” indicates a significant difference between the Lena and Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted 
pairwise Wilcoxon‑Mann‑Whitney test (p < 0.05).
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60% until the end of the experiment without any differ-
ences between strains. Correlation analyses showed that, 
for both strains, BALF macrophage count was associ-
ated with phagocytic cell percentage (r =  0.72 and 0.86 
for Lena and Finistere, respectively) and was inversely 
related to viral load (r = −0.63 and −0.74 for Lena and 
Finistere, respectively).
Conversely, the [SWC3+  , SWC9−, SWC8−] mono-
cyte population increased in BALF from 8 to 15 dpi (up 
to 26% for Lena, 17% for Finistere), the increase being 
significant only in the Lena strain (p = 0.018) (Figure 5B). 
Change in [SWC3+  , SWC9−, SWC8+] granulocytes 
was not observed in BALF (data not shown).
Without infection, lymphocytes were rarely detected 
in BALF. The proportion of CD3+  T cells increased up 
to 18 and 25% from 15 dpi for the Lena- and Finistere-
infected pigs, respectively (Figure  5C). CD21+  B cells 
increased in BALF only at 22 dpi for the Finistere infec-
tion (Figure 5D).
Dynamics of inflammation‑related cytokines in BALF 
and serum
PRRSV infection induced IFN-α production in BALF 
with an early increase for the Lena infection (maxi-
mum mean values of 61 U/mL at 4 dpi for Lena and 
69 U/mL at 11 dpi for the Finistere strain) (Figure 6A). 
In serum, high IFN-α levels were detected after Lena 
infection (maximum mean value of 964 U/mL at 2 
dpi), whereas the Finistere strain simultaneously 
induced lower IFN-α levels (maximum mean value of 
114 U/mL at 2 dpi) (Figure  6B). Similar results were 
obtained for TNF-α. Compared with the Finistere 
infection, earlier TNF-α induction was observed in 
BALF and higher quantities were detected in serum for 
the Lena infection (Figures 6C and D). Serum levels for 
IFN-α and TNF-α were correlated with hyperthermia 
in Lena-infected pigs (r = 0.61 and 0.51, respectively), 
but not in Finistere-infected pigs. The post-infection 
modulation of IL-1β level showed a different pro-
file, with higher production induced in BALF than in 
serum compared with pre-infection levels. In BALF 
collected from Lena-infected group, the IL-1β level 
was significantly higher than in Control group from 4 
to 15 dpi with maximum mean value of 489 pg/mL at 
11 dpi. In BALF collected from the Finistere-infected 
group, the increase of IL-1β was shortened from 8 to 
11 dpi and was weaker than in the Lena-infected group 
with maximum value of 183  pg/mL at 11 dpi (Fig-
ure  6E). In serum, no significant modulation of the 
IL-1β level was observed for the Finistere infection. 
The IL-1β level increased slightly in serum from the 
Lena-infected group (Figure 6F). Likewise, Lena infec-
tion led to a high amount of IL-8 in BALF from 8 to 15 
dpi, reaching 1129 pg/mL at 11 dpi, whereas no signifi-
cant levels of IL-8 were detected in BALF for the Fin-
istere infection (Figure 6G). In serum, IL-8 levels were 
low in all three groups (Figure  6H). BALF IL-1β or 
IL-8 levels and clinical score were strongly correlated 
in the Lena group (r = 0.86 and 0.89 respectively), but 
not in the Finistere group. IL-1β levels were inversely 
correlated with the viability of BALF cells in the Lena 
group (r  =  −0.710), as well as in the Finistere group 
(r = −0.540).
Dynamics of cell‑mediated immunity‑related cytokines 
in BALF and serum
Compared with the Finistere-infected group, Lena-
infected pigs showed high IFN-γ levels from 8 to 15 dpi 
in BALF (487 and 196 pg/mL at 11 dpi for the Lena- and 
Finistere-infected-groups, respectively, p  =  0.035) (Fig-
ure 7A). In serum, IFN-γ was not detected by ELISA for 
any group.
Figure 4 BALF cell viability and phagocytic activity. A Viability of BALF cells was evaluated using haemocytometer with Trypan blue. B Per‑
centage and C median of fluorescence intensity of phagocytic BALF cells were assessed by flow cytometry. All data are reported as the mean (±SE) 
of results obtained for the pigs in Control or Finistere group (n = 5 for each) or the surviving pigs (n = 5–8) in Lena group. “a” indicates a significant 
difference between the Control and Lena groups, “b” a significant difference between the Control and Finistere groups and “c” a significant differ‑
ence between the Lena and Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted pairwise Wilcoxon‑Mann‑Whitney test 
(p < 0.05).
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We further investigated the cellular origin of IFN-γ 
detected in BALF by studying IFN-γ gene expression 
in BALF cells by RT-PCR. The results showed an over-
expression of IFN-γ after PRRSV infection in cells iso-
lated from BALF compared with the basal expression 
level in these cells before infection (−3 dpi). PRRSV 
infection with Lena strain showed a stimulation of 
IFN-γ gene expression from 4 dpi with maximum value 
obtained at 11 dpi, the same day as the maximum IFN-γ 
level in BALF by ELISA (Figure 7B). Compared with the 
Lena infection, the Finistere infection showed signifi-
cantly lower IFN-γ gene expression in BALF cells from 4 
to 11 dpi (p = 0.018 at 4 and 8 dpi; p = 0.024 at 11 dpi).
Immunosuppressive cytokine IL-10 was assessed by 
ELISA, but could not be detected in BALF or serum 
from any of the pigs. Although the IL-10 protein was not 
detected by ELISA, expression of IL-10 gene was meas-
ured in BALF cells using RT-PCR. Up-regulation of IL-10 
gene expression occurred in BALF cells after PRRSV 
infection without any difference between strains, and 
only a delayed increase observed for the Finistere strain 
(increase from 4 dpi for Lena and 8 dpi for the Finistere 
infection) (Figure 7C).
Discussion
As previously described, we observed severe respiratory 
disorders and high fever after infection with the geno-
type 1.3 Lena strain, but very mild clinical signs with a 
typical genotype 1.1 strain [7, 17]. Furthermore, despite 
the absence of any other pathogen, this study showed 
Figure 5 BALF cell subsets. Percentages of (A) [SWC3+ ,SWC9+ , SWC8−] macrophages, (B) [SWC3+ ,SWC9−, SWC8−] monocytes, (C) [CD3+] 
T cells and (D) [CD21+] B cells were measured in BALF using flow cytometry. All data are reported as the mean (±SE) of results obtained for the 
pigs in the Control or Finistere groups (n = 5 in each group) or the surviving pigs (n = 5–8) in the Lena group. “a” indicates a significant difference 
between the Control and Lena groups, “b” a significant difference between the Control and Finistere groups and “c” a significant difference between 
the Lena and Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted pairwise Wilcoxon‑Mann‑Whitney test (p < 0.05).
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Figure 6 Pro-inflammatory cytokine profiles in BALF and serum. Cytokine levels were quantified in BALF (A, C, E, G) and sera (B, D, F, H) 
using ELISA for (A, B) IFN‑α, (C, D) TNF‑α, (E, F) IL‑1β and (G, H) IL‑8. All data are reported as the mean (±SE) of results obtained for the pigs in the 
Control or Finistere groups (n = 5 in each group) or the surviving pigs (n = 5–8) in the Lena group. “a” indicates a significant difference between the 
Control and Lena groups, “b” a significant difference between the Control and Finistere groups and “c” a significant difference between the Lena and 
Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted pairwise Wilcoxon‑Mann‑Whitney test (p < 0.05).
Page 10 of 14Renson et al. Vet Res  (2017) 48:15 
high mortality in SPF Lena-infected pigs, which confirms 
its qualification as highly pathogenic. Previous stud-
ies have described the death of 4 out of 10 conventional 
pigs after Lena infection, whereas no mortality occurred 
in SPF cross-breeds between the Great Yorkshire, Large 
White type and Dutch Landrace [7, 17]. Susceptibility to 
PRRSV infection may vary with pig breed, as suggested 
by Lewis et al. [29], and may explain the high mortality 
rate we observed in pure Large White SPF pigs. More 
severe disease symptoms have already been reported 
for HP-PRRSV infection in Large White pigs compared 
with either indigenous Chinese or Tibetan breeds [30, 
31]. Furthermore, in our study, the mortality observed 
in SPF pigs could be exacerbated by commensal micro-
organisms that became pathogenic in the context of 
Lena-induced immunosuppression. This second hypoth-
esis is supported by the lesions observed (fibrinous peri-
tonitis) in 2 out of the 3 dead Lena-infected pigs (#4915 
and #4917).
We hereby provide the first report of severe and long-
lasting anaemia after Lena infection. Using genotype 2 
PRRSV strains, Halbur et al. showed that severity of anae-
mia depends on strain virulence and suggested that the 
anaemia was probably due to a direct or indirect effect of 
the virus on erythroid precursor cells in the bone marrow 
[32]. Similarly, anaemia may have exacerbated the respir-
atory disorders in Lena-infected pigs by reducing the gas 
exchanges in the lungs [33].
In this study, we focused on investigating PAMs, which 
are the primary target cells for PRRSV replication, with 
relation to clinical score that reflects the virulence of the 
strain. Comparisons with blood were then carried out to 
identify lung-specific events. In the literature, reports of 
the relationships between pathogenicity and PRRSV rep-
lication level are contradictory, especially in lung [8, 34]. 
As in other studies [17, 35–37], our results support the 
concept that HP strains induce higher viremia, as well as 
higher viral load in lung than LP strains [17, 35–37]. On 
the other hand, we demonstrated, as Weesendorp et al. in 
lung tissues [20], that the Lena strain is cleared faster in 
BALF than the Finistere strain, suggesting a longer per-
sistence of genotype 1.1 LP-PRRSV strains in the lungs, 
which may contribute to longer susceptibility to second-
ary infections of pigs infected by LP strains.
In this study, we showed a faster reduction in viable 
cells, phagocytic cells and the macrophage population 
in BALF in the Lena group. We assume that cell death 
occurs in BALF macrophages (also identified as PAMs), 
which are phagocytic cells. In vitro, an increase of apop-
tosis in PAMs has been described after PRRSV infection 
[38] with extensive severity for the Lena strain [39]. In 
lung, a higher number of apoptotic cells was observed 
after infection by the genotype 1.3 HP-PRRSV SU1-Bel 
strain compared with 1.1 LP-PRRSV strains [40]. Inter-
estingly, in our study, cellular viability in BALF was corre-
lated with viral load, but also with IL-1β levels. As IL-1β 
is known to induce pyroptosis [41, 42], it suggests that 
the decrease in macrophages observed in BALF may be 
due to the direct effect of PRRSV infection, as well as to 
the effect of pro-apoptotic cytokines such as IL-1β.
In addition to the reduction in phagocytic cell num-
ber, resulting from the reduction of macrophage popula-
tion, phagocytic activity decreased within the remaining 
phagocytic cells after PRRSV infection with a faster and 
stronger effect for the Lena strain. Down-regulation of 
the phagocytic capacity of PRRSV-infected PAMs has 
Figure 7 IFN-γ and IL-10 quantifications in BALF. A IFN‑γ level was quantified in BALF using ELISA. B IFN‑γ and C IL‑10 gene expressions were 
measured in BALF cells by RT‑PCR. The presented values are the relative expressions calculated from the cycle threshold (Ct) results on each post‑
infection day as a function of those obtained the day before the infection as described in “Materials and methods” section. All data are reported as 
the mean (±SE) of results obtained for the pigs in the Control or Finistere group (n = 5 in each group) or the surviving pigs (n = 5–8) in Lena group. 
“a” indicates a significant difference between the Control and Lena groups, “b” a significant difference between the Control and Finistere groups 
and “c” a significant difference between the Lena and Finistere groups using a global Kruskal–Wallis test followed by a Holm’s adjusted pairwise 
Wilcoxon‑Mann‑Whitney test (p < 0.05).
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previously been shown in  vitro; our study presents the 
first evidence in  vivo [23, 43]. Phagocytosis impairment 
and, consequently, the decrease in the bactericidal activ-
ity of macrophages in BALF may contribute to lung dam-
age by compromising homeostasis and favouring the 
development of secondary bacterial infections. Thereaf-
ter, renewal of macrophages in BALF may be triggered 
by an influx of monocytes from blood at 8–11 dpi (with 
more efficient recruitment in Lena infection), which may 
promote virus replication and exacerbate the production 
of inflammatory cytokines. However, recent studies have 
shown that some macrophages can originate and renew 
in adult tissues independently from hematopoietic stem 
cells, but derived instead from yolk sac foetal monocytes 
[44, 45].
After having investigated the macrophage popula-
tion and their activity, we then extended our study to 
the cytokines present in BALF. In blood, as previously 
described [16, 17], PRRSV infection with HP strains 
enhanced pro-inflammatory response compared with 
LP strains [16, 17]. We showed that IFN-α or TNF-α 
response in blood correlates with the hyperthermia 
observed after Lena infection. Our results support the 
hypothesis that the stronger systemic inflammatory 
response induced after HP strains infection is respon-
sible for the high fever that specifically occurs with 
these strains. In contrast, in BALF, the major differ-
ence between strains was a lag in onset of the IFN-α or 
TNF-α maximum levels in the Finistere strain infection. 
These results suggest weak stimulation of Lena strain in 
the lung and indicate that the high levels of IFN-α and 
TNF-α detected in the blood are probably produced in 
other tissues. This low induction of IFN-α or TNF-α in 
lung is well described for PRRSV infection and reflects 
the PRRSV evasion from the host innate response [46–
49]. Comparing different respiratory pathogens, levels 
of pro-inflammatory cytokines in lung have been linked 
to the severity of the pulmonary lesions [15]. There were 
no significant differences in IFN-α or TNF-α maximum 
levels between the Lena and Finistere strains, suggesting 
that IFN-α and TNF-α are not the main inflammatory 
cytokines involved in lung damage.
Interestingly, the low modulations detected for IFN-α 
and TNF-α levels contrast with exacerbated levels of 
IL-1β and IL-8 measured in BALF. Even if no effect of 
the repeated bronchoalveolar lavages was noticed in the 
Control group, we cannot completely exclude an addi-
tional effect of BAL in inducing inflammation in the 
lungs of PRRS infected animals. However, up-regulation 
of IL-1β gene expression in lung after Lena-infection 
has previously been reported by Weesendorp el al. [20]. 
Amarilla et  al. recently showed a correlation between 
IL-1α and the intensity of clinical signs and lung lesions 
in pigs infected with the HP SU1-bel PRRSV strain [50]. 
Our results confirm and provide further evidence for a 
relationship between IL-1β levels in lung and the severity 
of the disease. Furthermore, our study presents the first 
evidence that IL-8 is over-produced after infection with 
an HP strain, but not LP strains, within the lungs. Previ-
ous studies on genotype 2 strains have reported the up-
regulation of IL-8 gene expression in PAMs isolated from 
infected pigs using a Chinese HP strain at 14 dpi [51] or 
in in vitro-infected PAMs using the VR-2332 strain [52]. 
Our results demonstrate a dramatic lung-specific IL-8 
protein production after infection with a HP strain com-
pared with a LP strain, suggesting an essential role of this 
cytokine in lung pathogenesis. IL-8 is a pro-inflammatory 
cytokine mainly secreted by monocytes and endothelial 
cells, which chemoattract neutrophils. For many res-
piratory pathogens such as the porcine influenza virus, 
A. pleuropneumoniae or M. hyopneumoniae, neutrophil 
lung infiltration causes pneumonia and is related to the 
severity of disease [53–55]. During PRRSV infection, 
neutrophil lung invasion is frequently described for HP 
strains [18, 20, 56]. The coincidence in IL-8 and mono-
cyte detection in BALF suggests that IL-8 may originate 
from recruited monocytes rather than PAMs in the Lena 
infection. Likewise, the high level of IL-1β induced dur-
ing the Lena infection may result from additional pro-
duction of IL-1β by recruited monocytes.
In viral infections, adaptive immunity can be influ-
enced by the innate response toward the interaction of 
IFN-α with dendritic cells, promoting the development 
of T cell-mediated IFN-γ responses to enhance anti-viral 
immune defences, or directly towards IFN-γ produced by 
NK cells [57]. Although low IFN-α levels were detected 
in BALF for both PRRSV strains, earlier IFN-α induction 
was observed in the Lena infection, which may promote a 
stronger IFN-γ response resulting in a faster virus clear-
ance in BALF than for the Finistere strain. The IFN-γ 
levels detected in BALF could also originate from NK 
cells as higher proportions of NK cells and CD8+ T cells 
were detected at 15 dpi in BALF from PRRSV-infected 
pigs (data not shown) and we could hypothesize that the 
increase of NK cells occurred earlier in Lena- than in Fin-
istere-infected pigs. IFN-γ has effectively been shown to 
inhibit viral replication in macrophages and MARC-145 
and is associated with clinical protection against PRRSV 
infection [58–60]. In our study, the high levels of IFN-γ 
measured in BALF from Lena-infected pigs corroborate 
previous results that show a similar IFN-γ response after 
infection with the HP genotype 1.3 SU1-bel strain [8], 
but contrast with the results indicating lower ELISPOT 
IFN-γ BALF cell response for the Lena strain than for 
the LP Lelystad strain at 35 dpi [20]. There was no dif-
ference in the immunosuppressive IL-10 gene expression 
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in BALF cells between strains, supporting a balance 
toward a stronger cell-mediated immune response and/
or a stronger innate NK cell response after Lena infection 
than after Finistere infection.
In conclusion, our data indicate that the HP Lena strain 
markedly alters the bronchoalveolar cellular populations 
and cytokines in conjunction with a high virus load and 
severe respiratory clinical signs. The PAM population 
reduced rapidly, coinciding with lower cellular viability 
and phagocytic activity that probably reduce the bacteri-
cidal activity of macrophages and increase susceptibility 
to secondary infections. The IL-1β and IL-8 inflammatory 
response was stronger in BALF for the Lena infection, 
and may promote lung damage and limit gas exchanges. 
In later stages of the PRRSV infection, faster viral clear-
ance in BALF from Lena-infected pigs may result from 
a more effective IFN-γ T cell and/or NK cell response. 
Improving the knowledge on PRRSV pathogenesis and 
on local immune responses induced post-vaccination can 
lead to the development of more efficient vaccine strate-
gies to control the disease.
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